Sign in Pull a receipt

ANL

Adlai Nortye Group Ltd.

Healthcare · Biotechnology

$50.80 sample

+0.47 (+0.93%) 1D

Market cap

$292.8B

Price as of

2026-10-24

Latest filing

8-K · 2026-09-02

Alerts

8

Price$50.80 +4.94% 3M daily closessample

52.6148.41

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider buy: Director
Oct 15INSInsider sell: Director
Oct 09INSInsider buy: General Counsel
Oct 06INSInsider buy: Chief Financial Officer
Sep 30INSInsider sell: Chief Executive Officer
Sep 21INSInsider sell: 10% owner
Sep 11INSInsider sell: Chief Executive Officer
Sep 02SECForm 144 filed

Sign up to see the real ANL record →

Company facts

SEC EDGAR registration

Name: Adlai Nortye Group Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +1sample, -100 to +100
Reporting currency: USD

Who is positioning in ANL

sample

Insiders: 31 insider transactions over 90 days, net selling, $814.8M
Congress: 4 members traded over 90 days
Institutions · 13F: 21 funds hold $4.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.7B +10.7% y/y

Q4 2024Q3 2026

Inventory$7.1B +17.6% y/y

Q4 2024Q3 2026

Accounts receivable$5.5B +18.4% y/y

Q4 2024Q3 2026

Total debt$14.1B +9.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $270.8B -11.9% 3M
Sample peer B: $278.4B -1.7% 3M
Sample peer C: $109.6B -5.1% 3M
Sample peer D: $210.6B +13.1% 3M
Sample peer E: $58.8B -11.8% 3M